CIK 0001850902
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Alpha Teknova, Inc.
Sign in to watch- Ticker
- TKNO
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943368109
- Phone
- +1 831-637-1100
- Business address
- 2451 BERT DRIVE, HOLLISTER, CA, 95023
- 4 Open-market sale Chief People Officer sold 3,119 shares at $2.04 ($6,351)
- 4 Open-market buy President and CEO bought 4,665 shares at $1.67 ($7,772)
- 4 Open-market buy Chief Commercial Officer bought 3,915 shares at $1.67 ($6,522)
- 4 Open-market buy Chief People Officer bought 3,119 shares at $1.67 ($5,196)
- 4 Grant or award General Counsel and CCO acquired 14,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 14,000 shares (grant or award)
- 4 Grant or award Chief People Officer acquired 14,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 43,125 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 14,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief People Officer bought 2,818 shares at an average $6.07 ($17,099)
- 4 Open-market buy President and CEO bought 3,008 shares at an average $7.11 ($21,387)
- 4 Open-market buy Chief Commercial Officer bought 1,422 shares at $4.23 ($6,019)
- 4 Exercise or conversion President and CEO acquired 40,000 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $4.61 ($46,096)
- 4 Open-market buy Director bought 10,000 shares at an average $4.98 ($49,750)
- 4 Open-market buy President and CEO bought 18,000 shares at $5.13 ($92,338)
- 4 Grant or award Director acquired 9,357 shares (grant or award)
- 4 Grant or award Director acquired 9,357 shares (grant or award)
Page 3 of 5 · 93 filings